Insulin release and peripheral sensitivity at the oral glucose tolerance test
Abstract
With the use of a 75 g oral glucose tolerance test, both insulin release (IRG) and the degree of peripheral sensitivity (SI) were evaluated simultaneously in groups with normal (NGT) and impaired (IGT) glucose tolerance as well as NIDDM. IRG was expressed as the ratio of the area under the insulin curve to that of the glucose curve above fasting levels. The peripheral glucose uptake rate (M) during the OGTT was measured as the difference between the glucose load and the increase in the amount of glucose in the glucose space during the oral glucose tolerance test (OGTT). SI was expressed as the ratio of the metabolic clearance rate (M/mean blood glucose) to log mean serum insulin. In the non-obese groups, both mean IRG and mean SI values were decreased with an increasing degree of hyperglycemia from NGT to NIDDM. Decreased mean SI values were also found in obese subjects. IGT-subjects given 3 months of diet and exercise achieved improved SI values. A non-obese NIDDM-group had higher mean IRG and mean SI values after 6 months of treatment with glipizide. The results were comparable to data obtained with more complicated techniques, such as the insulin clamp and suppression tests, and should be easy to apply on a large scale in epidemiological studies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Late-reactive hypoglycemia may be a predictor of diabetes.
“For all these reasons, late-reactive hypoglycemia may be a predictor of diabetes.[30–32]”
From Postprandial Reactive Hypoglycemia (2019) · cites this paper as [30]
The Cederholm index of peripheral insulin sensitivity has been validated against the hyperinsulinemic-euglycemic clamp.
“Glucose and insulin concentrations during the OGTT were used to calculate the Cederholm index of peripheral insulin sensitivity (32), which has been validated against the hyperinsulinemic-euglycemic clamp (33).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [32]
Cites
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909 · see citing works
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · see citing works
Assessment of insulin sensitivity in vivo.
Bergman, R., Finegood, D., & Ader, M. (1985) · Endocrine reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,215 · see citing works
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917 · see citing works
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 819 · see citing works
Diabetes Mellitus: Theory and Practice.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-2-330_2 · Cited by 567 · see citing works
Assessment of Insulin Resistance with the Insulin Suppression Test and the Euglycemic Clamp
Greenfield, M. S., Doberne, L., Kraemer, F. B., Tobey, T. A., & Reaven, G. M. (1981) · Diabetes · doi:10.2337/diab.30.5.387 · Cited by 366 · see citing works
Nonketotic diabetes mellitus: Insulin deficiency or insulin resistance?
Reaven, G. M., Bernstein, R., Davis, B. M., & Olefsky, J. M. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90536-2 · Cited by 356 · see citing works
Diabetes Mellitus: Theory and Practice.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-827_1 · Cited by 326 · see citing works
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
Kadowaki, T., Miyake, Y., Hagura, R., Akanuma, Y., Kajinuma, H., Kuzuya, N., Takaku, F., & Kosáka, K. (1984) · Diabetologia · doi:10.1007/bf00252262 · Cited by 315 · see citing works
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296 · see citing works
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
DeFronzo, R. A., Ferrannini, E., & Koivisto, V. A. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90654-x · Cited by 263 · see citing works
Reaven, G. M., Hollenbeck, C. B., & Chen, Y. D. I. (1989) · Diabetologia · doi:10.1007/bf00265404 · Cited by 186 · see citing works
Kosáka, K., Hagura, R., & Kuzuya, T. (1977) · Diabetes · doi:10.2337/diab.26.10.944 · Cited by 152 · see citing works
Reaven, G. M., & Dray, J. M. (1967) · Diabetes · doi:10.2337/diab.16.7.487 · Cited by 146 · see citing works
Influence of Maturity-onset Diabetes on Splanchnic Glucose Balance After Oral Glucose Ingestion
Felig, P., Wahren, J., & Hendler, R. (1978) · Diabetes · doi:10.2337/diab.27.2.121 · Cited by 127 · see citing works
Enhanced Glucose Utilization During Prolonged Glucose Clamp Studies
Doberne, L., Greenfield, M. S., Schulz, B., & Reaven, G. M. (1981) · Diabetes · doi:10.2337/diab.30.10.829 · Cited by 120 · see citing works
Greenfield, M. S., Doberne, L., Rosenthal, M. J., Schulz, B., Widström, A., & Reaven, G. M. (1982) · Diabetes · doi:10.2337/diab.31.4.307 · Cited by 117 · see citing works
Effect of Chronic Sulfonylurea Therapy on Plasma Insulin and Proinsulin Levels
Duckworth, W. C., Solomon, S. S., & Kitabchi, A. E. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-4-585 · Cited by 115 · see citing works
Relationship between in Vivo Insulin Resistance and Decreased Insulin Receptors in Obese Man*
KOLTERMAN, O. G., REAVEN, G. M., & OLEFSKY, J. M. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-3-487 · Cited by 85 · see citing works
Reaven, G. M., & Olefsky, J. M. (1977) · Diabetologia · doi:10.1007/bf01219700 · Cited by 83 · see citing works
Sheldon, J. H., Taylor, K. W., & Anderson, J. V. (1966) · Metabolism · doi:10.1016/0026-0495(66)90158-2 · Cited by 53 · see citing works
Sulfonylurea treatment of insulin-independent diabetes mellitus
Feinglos, M. N., & Lebovitz, H. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90175-4 · Cited by 47 · see citing works
Cederholm, J., & Wibell, L. B. (1985) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518509155289 · Cited by 46 · see citing works
Self-citationde Nobel, E., & Laar, A. V. '. (1978) · Diabetes · doi:10.2337/diab.27.1.42 · Cited by 43 · see citing works
Kolterman, O., PRINCE, M. J., & Olefsky, J. M. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90655-1 · Cited by 36 · see citing works
Glipizide versus tolbutamide, an open trial
Fineberg, S. E., & Schneider, S. H. (1980) · Diabetologia · doi:10.1007/bf01228302 · Cited by 30 · see citing works
On a Mathematical Model for the Analysis of the Glucose Tolerance Curve
Corte, M. D., Romano, S. M., Voeghelin, M. R., et al. (1970) · Diabetes · doi:10.2337/diab.19.6.445 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900 · see citing works
Babraj, J. A., Vollaard, N. B., Keast, C., Guppy, F. M., Cottrell, G., & Timmons, J. A. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-3 · Cited by 374 · see citing works
Metcalfe, R. S., Babraj, J. A., Fawkner, S. G., & Vollaard, N. B. J. (2012) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2254-z · Cited by 294 · see citing works
Evaluation of insulin sensitivity in clinical practice and in research settings
Monzillo, L. U., & Hamdy, O. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.dec.397-412 · Cited by 259 · see citing works
Measuring and estimating insulin resistance in clinical and research settings
Gastaldelli, A. (2022) · Obesity · doi:10.1002/oby.23503 · Cited by 244 · see citing works
Gillen, J. B., Percival, M. E., Ludzki, A., Tarnopolsky, M. A., & Gibala, M. J. (2013) · Obesity · doi:10.1002/oby.20379 · Cited by 222 · see citing works
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
Rantala, A. O., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00429.x · Cited by 211 · see citing works
Ibáñez, L., Potau, N., Zampolli, M., RiquÉ, S., Saenger, P., & Carrascosa, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4084 · Cited by 199 · see citing works
Simvastatin Effects on Skeletal Muscle
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165 · see citing works
Ibanez, L., Potau, N., Zampolli, M., Prat, N., Virdis, R., Vicens-Calvet, E., & Carrascosa, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772605 · Cited by 138 · see citing works
Impaired insulin secretion in the Turner metabolic syndrome
Bakalov, V. K., Cooley, M. M., Quon, M. J., Luo, M. L., Yanovski, J. A., Nelson, L. M., Sullivan, G., & Bondy, C. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0122 · Cited by 137 · see citing works
Brief Intense Stair Climbing Improves Cardiorespiratory Fitness
ALLISON, M. K., BAGLOLE, J. H., MARTIN, B. J., MACINNIS, M. J., GURD, B. J., & GIBALA, M. J. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001188 · Cited by 116 · see citing works
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
Fernández‐Real, J. M., Ricart Engel, W., Simó, R., Salinas, I., Webb, S. M., & and the Study Group of Incidental Adrenal Adenoma (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00437.x · Cited by 109 · see citing works
Honsek, C., Kabisch, S., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Dambeck, U., Osterhoff, M. A., Weickert, M. O., & Pfeiffer, A. F. H. (2018) · Diabetologia · doi:10.1007/s00125-018-4582-6 · Cited by 63 · see citing works
Hulman, A., Vistisen, D., Glümer, C., Bergman, M., Witte, D. R., & Færch, K. (2018) · Diabetologia · doi:10.1007/s00125-017-4468-z · Cited by 60 · see citing works
Postprandial Reactive Hypoglycemia
Altuntaş, Y. (2019) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2019.59455 · Cited by 47 · see citing works
Kabisch, S., Meyer, N. M. T., Honsek, C., Gerbracht, C., Dambeck, U., Kemper, M., Osterhoff, M. A., Birkenfeld, A. L., Arafat, A. M., Hjorth, M. F., et al. (2019) · Nutrients · doi:10.3390/nu11102385 · Cited by 38 · see citing works
Piché, M.-È., Lemieux, S., Corneau, L., Nadeau, A., Bergeron, J., & Weisnagel, S. J. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.002 · Cited by 31 · see citing works
Kabisch, S., Meyer, N. M. T., Honsek, C., Gerbracht, C., Dambeck, U., Kemper, M., Osterhoff, M. A., Birkenfeld, A. L., Arafat, A. M., Weickert, M. O., et al. (2019) · Nutrients · doi:10.3390/nu11112726 · Cited by 20 · see citing works
- Authors
- Cederholm, J., & Wibell, L.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Cederholm, Jan
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 1990-10
- Volume
- 10
- Issue
- 2
- Pages
- 167-175
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2050110272
- Cited by
- 264
- References
- 28
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 11 · 2023: 3 · 2022: 11 · 2021: 8 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 12 · 2016: 14 · 2015: 14 · 2014: 12 · 2013: 11 · 2012: 2
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Research and Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin secretion, insulin sensitivity, oral glucose tolerance test, impaired glucose tolerance, type 2 diabetes, peripheral glucose uptake, hyperglycemia, obesity, diet and exercise therapy, glipizide
- MeSH terms
- Insulin Secretion, Aged, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin, Male, Middle Aged, Obesity, Reference Values
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review